Skin Cells Turned Into Cancer Killers?


Pharmacy researchers from the University of North Carolina at Chapel Hill have done something its men’s basketball team will never be accused of doing, studying. With all that book learning the researchers have achieved a scientific first; turning skin cells into cancer-hunting stem cells that home in on brain tumors known as glioblastoma with murderous intent.

Source: The Blue Diamond Gallery

Skin cells working off Nobel-winning advances from 2007

For the first time in over three decades, a new treatment may become available for sufferers of brain cancer with tumors diagnosed as glioblastoma. While it may be difficult to imagine a good type of brain cancer, there are less pernicious tumors than glioblastomas. Less than 30% of patients diagnosed see a life two-years down the road as surgery has little effect on the tendrils that remain following the removal of the tumor. The remaining tendrils simply build a new house in your brain.

The roughly 30% that survive beyond the aforementioned two-year window invariable die before the three year mark has passed. However, there is hope that this may change. Using Nobel-winning medicine, the pharmacy researchers were able to “reprogram” the patients’ (mice) skin cells to roam the brain seeking out remaining cancer cells following the removal of the tumor.

After A Tough Year, Odey Asset Management Finishes 2021 On A High

For much of the past decade, Crispin Odey has been waiting for inflation to rear its ugly head. The fund manager has been positioned to take advantage of rising prices in his flagship hedge fund, the Odey European Fund, and has been trying to warn his investors about the risks of inflation through his annual Read More

“Patients desperately need a better standard of care,” said Shawn Hingtgen, Ph.D., an assistant professor in the UNC Eshelman School of Pharmacy and member of the Lineberger Comprehensive Care Center, who led the study.

Survival rate in mice drastically increased

The skin cells, or fibroblasts, were induced into a life as neural stem cells and let loose in the brain of the subjects (it’s just nicer to write than acknowledging that they gave mice brain cancer) where the hunted cancer cells with aplomb without damaging non-cancerous cells. While the results varied based on tumor type, the team increased the survival time in mice by 160 to 220 percent. The researchers also wrote that they enjoyed success engineering the skin cells cum “cancer killers” into producers of a protein that also kills tumors.

“Our work represents the newest evolution of the stem-cell technology that won the Nobel Prize in 2012,” Hingtgen said. “We wanted to find out if these induced neural stem cells would home in on cancer cells and whether they could be used to deliver a therapeutic agent. This is the first time this direct reprogramming technology has been used to treat cancer.”

The team is now planning to double down on its findings by concentrating on human stem cells while at the same looking at the potential for its breakthrough with skin cells working in conjunction with promising anti-cancer medications.

Hingtgen’s team is a busy unit with members also working to improve the long-term performance of stem cells in the surgical cavity. The team is looking to build a figurative backbone in order to support, organize and rally the cancer-killing cells. Stem cells need direction and by providing a physical matrix the team hopes to keep the stem cells interested in their fight against the remaining cancerous tendrils. Similar to a parent justifying the prescribing of Adderall to a child that simply daydreams.

“Without a structure like that, the stem cells wander off too quickly to do any good,” said Hingtgen, in a separate study published in the journal Biomaterials.

Updated on

While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. <i>To contact Brendan or give him an exclusive, please contact him at [email protected]</i>
Previous article Ways Technology Can Make You A Smarter Investor
Next article A Framework For Assessing The Systemic Risk Of Major Financial Institutions

No posts to display